NJGK(600064)
Search documents
南京高科(600064) - 南京高科2024年年度股东会会议材料
2025-05-21 09:30
2024 年年度股东会会议材料 南京高科股份有限公司 2024 年年度股东会会议材料 (2025 年 5 月) 见证律师 其他相关人员 2024 年年度股东会会议材料 南京高科股份有限公司 2024 年年度股东会 一、现场会议安排 召开时间:2025 年 5 月 30 日下午 2:00 召开地点:南京高科股份有限公司会议室 参会人员:公司股东及股东代表 公司董事、监事、高级管理人员 主 持 人:董事长徐益民先生 二、网络投票安排 网络投票系统:上海证券交易所股东大会网络投票系统 网络投票起止时间:自 2025 年 5 月 30 日 至 2025 年 5 月 30 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投 票时间为股东会召开当日的交易时间段,即 9:15-9:25,9:30-11:30, 13:00-15:00;通过互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 三、现场会议议程 (一)会议主持人介绍股东出席情况,介绍到会董事、监事、高 级管理人员、见证律师及其他相关人员情况; (二)会议主持人宣布会议开始; (三)宣读、审议议案: 1、审议《2024 年度董事会工作报告 ...
栖霞建设:股东南京高科拟减持不超过公司总股本的3%
news flash· 2025-05-21 08:56
Group 1 - The core point of the article is that shareholder Nanjing Gaoke plans to reduce its stake in Qixia Construction by up to 3% of the total share capital within three months through centralized bidding and block trading [1] - The reduction will involve a maximum of 31.5 million shares, which are sourced from shares obtained prior to the IPO and those acquired through non-public offerings and profit distribution after the listing [1]
南京高科股份有限公司 关于2024年年度股东会补充公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-15 23:15
Group 1 - The company is holding its 2024 Annual General Meeting on May 30, 2025 [1] - The original notice for the AGM omitted a resolution regarding the change of the company's business scope and the amendment of relevant articles in the Articles of Association, which has now been added as a special resolution [2] - The original notice of the AGM remains unchanged aside from the added resolution [3] Group 2 - The AGM will take place at 14:00 on May 30, 2025, in the company's conference room [5] - Online voting will be conducted through the Shanghai Stock Exchange's shareholder meeting online voting system, available from 9:15 to 15:00 on the day of the meeting [5] - The record date for shareholders to participate in the AGM remains unchanged [6] Group 3 - Non-voting matters include listening to the independent directors' 2024 annual work report [7]
南京高科(600064) - 南京高科关于2024年年度股东会补充公告
2025-05-15 09:32
证券代码:600064 证券简称:南京高科 公告编号:临 2025-016 号 南京高科股份有限公司 关于2024年年度股东会补充公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、 股东会有关情况 1. 原股东会的类型和届次: 2024年年度股东会 | 股份类别 | 股票代码 | 股票简称 | 股权登记日 | | --- | --- | --- | --- | | A股 | 600064 | 南京高科 | 2025/5/26 | 二、 更正补充事项涉及的具体内容和原因 南京高科股份有限公司(以下简称"公司")于 2025 年 4 月 23 日披露了《南 京高科股份有限公司关于召开 2024 年年度股东会的通知》(公告编号:临 2025-013 号),经核查,本次股东会通知遗漏了《关于变更公司经营范围暨修订 〈公司章程〉相关条款的议案》,该议案已经公司 2024 年 11 月 1 日第十一届董 事会第四次会议审议通过,具体详见公司临 2024-040 号公告。现将本次股东会 审议议案在原议案基础上增加《关于变更公司经营范 ...
南京高科股份有限公司 关于召开2024年度业绩说明会的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-05-06 23:02
Group 1 - The company will hold a 2024 annual performance briefing on May 15, 2025, from 15:00 to 16:30 [3][6] - The briefing will be conducted via the "Nanjing Gaoke Investor Relations" mini-program, combining live video and text interaction [3][6] - Investors can submit questions through the mini-program or via email by May 14, 2025, and the company will address common inquiries during the briefing [4][2] Group 2 - Key personnel attending the briefing include the Chairman Xu Yimin, President Lu Yangjun, Independent Director Li Minghui, and other executives [3][6] - The company has previously disclosed its 2024 annual report and summary on various financial news platforms and the Shanghai Stock Exchange website [2]
南京高科(600064) - 南京高科关于召开2024年度业绩说明会的公告
2025-05-06 08:15
证券简称:南京高科 证券代码:600064 编号:临 2025-015 号 南京高科股份有限公司 关于召开 2024 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 投资者可于 2025 年 5 月 14 日(星期三)前通过"南京高科投资者关系" 小程序或者公司邮箱 600064@600064.com 联系公司进行提问。公司将在业绩说 明会上对投资者普遍关注的问题进行回答。 一、说明会类型 公司已于 2025 年 4 月 23 日在《中国证券报》《上海证券报》《证 券时报》及上海证券交易所网站(www.sse.com.cn)上披露了 2024 年年度报告及摘要。为让广大投资者更全面深入地了解公司经营业绩 和利润分配等具体情况,公司决定以网络互动方式举行 2024 年度业 绩说明会。 二、说明会召开时间和形式 召开时间:2025 年 5 月 15 日(周四)15:00-16:30 召开地址: "南京高科投资者关系"小程序 召开方式:网络视频直播结合文字互动 1 会议召开时间:2025 ...
南京高科:公司信息更新报告:地产业务收缩影响营收,归母净利润同比增长-20250423
KAIYUAN SECURITIES· 2025-04-23 08:23
Investment Rating - The investment rating for the company is "Buy" (maintained) [4] Core Views - The company's revenue has decreased due to a contraction in its real estate business, while the net profit attributable to the parent company has increased year-on-year. The company is expected to see continuous improvement in performance due to its strong financing channels [4][5] - The company has provided profit forecasts for 2025-2027, estimating net profits of 2.21 billion, 2.46 billion, and 2.59 billion yuan respectively, with corresponding EPS of 1.3, 1.4, and 1.5 yuan. The current stock price corresponds to PE ratios of 5.7, 5.2, and 4.9 times [4][5] Financial Performance Summary - In 2024, the company achieved operating revenue of 1.98 billion yuan, a year-on-year decrease of 58.16%, while the net profit attributable to the parent company was 1.73 billion yuan, a year-on-year increase of 10.58%. The net profit excluding non-recurring items was 1.62 billion yuan, down 1.54% year-on-year [5][8] - The company's gross margin and net margin for 2024 were 21.88% and 83.09%, respectively, reflecting increases of 9.55 percentage points and 51.72 percentage points year-on-year [5][8] - The company's real estate business saw a significant decline in revenue, with a year-on-year decrease of 84.09% in operating income from real estate development [6][8] Sales and Contract Performance - The company reported a contract sales area of 18,700 square meters in 2024, a year-on-year decrease of 92.66%, and a contract sales amount of 620 million yuan, down 67.59% year-on-year [6] - New construction area and completed area also saw significant declines of 80.78% and 61.93% year-on-year, respectively [6] Financing and Cost Management - The company has maintained smooth financing channels, with an average financing cost of 2.72% in 2024, a decrease of 0.27 percentage points compared to the same period in 2023 [7] - The company has authorized borrowing up to 2 billion yuan from Nanjing Bank, with a loan balance of 300 million yuan as of the end of 2024 [7]
南京高科(600064):公司信息更新报告:地产业务收缩影响营收,归母净利润同比增长
KAIYUAN SECURITIES· 2025-04-23 06:51
Investment Rating - The investment rating for the company is "Buy" (maintained) [4] Core Views - The company's revenue has decreased due to a contraction in its real estate business, while the net profit attributable to shareholders has increased year-on-year. The company is expected to see continuous improvement in performance due to its strong financing channels [4][5] - The company has provided profit forecasts for 2025-2027, estimating net profits of 2.21 billion, 2.46 billion, and 2.59 billion yuan respectively, with corresponding EPS of 1.3, 1.4, and 1.5 yuan. The current stock price corresponds to PE valuations of 5.7, 5.2, and 4.9 times [4][5] Financial Performance Summary - In 2024, the company achieved operating revenue of 1.98 billion yuan, a year-on-year decrease of 58.16%. The net profit attributable to shareholders was 1.73 billion yuan, a year-on-year increase of 10.58%. The net profit excluding non-recurring items was 1.62 billion yuan, a year-on-year decrease of 1.54% [5][8] - The company's operating cash flow was -500 million yuan in 2024, with a gross margin of 21.88% and a net margin of 83.09%, reflecting increases of 9.55 percentage points and 51.72 percentage points year-on-year respectively [5][8] - The real estate business saw a significant decline in revenue, with a year-on-year decrease of 84.09% in operating income from real estate development [5][6] Real Estate Business Overview - The company reported a contract sales area of 18,700 square meters in 2024, a year-on-year decrease of 92.66%, and a contract sales amount of 620 million yuan, a year-on-year decrease of 67.59% [6] - New construction area decreased by 80.78% year-on-year, while the completed area decreased by 61.93% [6] Financing and Cost Management - The company has maintained smooth financing channels, with an average financing cost of 2.72% in 2024, down 0.27 percentage points from the same period in 2023 [7] - The company has authorized borrowing up to 2 billion yuan from Nanjing Bank, with a loan balance of 300 million yuan as of the end of 2024 [7] Financial Metrics and Projections - The company’s financial metrics for 2023A to 2027E show a projected operating revenue of 2.24 billion yuan in 2025E, with a year-on-year growth of 13.6% [8][11] - The projected net profit for 2025E is 2.21 billion yuan, reflecting a year-on-year growth of 28.4% [8][11] - The company’s P/E ratio is projected to decrease from 5.7 in 2025E to 4.9 in 2027E, indicating an improving valuation [8][11]
南京高科(600064) - 南京高科关于续聘会计师事务所的公告
2025-04-22 10:09
证券简称:南京高科 证券代码:600064 编号:临 2025-012 号 南京高科股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 拟聘任的会计师事务所名称:天衡会计师事务所(特殊普通合伙) 一、拟聘任会计师事务所的基本情况 (一)机构信息 1、基本信息 (9)财务信息及客户情况:天衡 2024 年度业务收入总额为 52,937.55 万元(人民币,下同),审计业务收入为 46,009.42 万元, 证券业务收入为 15,518.61 万元。天衡 2023 年度上市公司审计客 户数量为 95 家,审计收费总额为 9,271.16 万元,主要行业包括制 造业,电力、热力、燃气及水生产和供应业,科学研究和技术服 务业,信息传输、软件和信息技术服务业,批发和零售业,文化、 体育和娱乐业等,与公司同行业(房地产业)的上市公司审计客 户 1 家。 2、投资者保护能力 2024 年末,天衡计提职业风险基金 2,445.10 万元,购买的职业 保险累计赔偿限额为 10,000. ...
南京高科(600064) - 南京高科未来三年(2025-2027年)分红规划
2025-04-22 10:09
南京高科股份有限公司 未来三年(2025-2027 年)分红规划 为提升公司投资价值,增强投资者回报,维护股东合法权益,根 据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司 监管指引第 3 号——上市公司现金分红》等法律法规及《公司章程》 相关规定,结合公司实际经营情况和发展战略,特制定《南京高科股 份有限公司未来三年(2025-2027 年)分红规划》(以下简称"分红规 划"),具体内容如下: 一、制定分红规划的背景与目的 背景:公司自上市以来,始终坚持稳健经营,积极回馈股东。为 明确投资者预期,建立科学、透明的分红机制,现制定未来三年分红 规划。 目的:平衡股东短期回报与公司长期发展需求,促进股东价值最 大化,提升公司治理水平。 二、现金分红的基本原则 合规性:符合《公司章程》及监管机构对利润分配的要求。 可持续性:以公司盈利能力和现金流为基础,兼顾股东合理回报 与公司发展需求。 公平性:确保全体股东,尤其是中小股东享有平等分红权益。 三、未来三年(2025-2027 年)分红具体规划 分红条件:公司当年实现盈利且累计未分配利润为正;现金流可 1 满足正常经营和战略投资需求;不存在重大投资计划 ...